Humaslin

product on market Capsule Condemned Safety: 95/100
95/100

This product looks safe

  • Vanadyl Sulfate: 20mg is 11.1× the Tolerable Upper Intake Level (1.8mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains ingredients like berberine and cinnamon, which have moderate evidence for supporting glucose metabolism. Alpha-lipoic acid and fenugreek are also included to assist with insulin sensitivity. Overall, the evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vanadyl Sulfate: 20mg is 11.1× the Tolerable Upper Intake Level (1.8mg)

Label

Product Label

Label for Humaslin
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Cinnamon
600 mg
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Gymnema Leaf Extract
400 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
Banaba Leaf Extract
50 mg
Exceeds UL by 11.1× (UL: 1.8 mg) 1 studies (A:0, B:1)
DigeSEB Enzyme Blend
100 mg

Other Ingredients

Gelatin Rice Flour Magnesium Stearate Silicon Dioxide Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement take three (3) capsules 15 minutes prior to consuming a meal rich in carbohydrates. For optimal results, stack Humalin with a high carbohydrate meal prior to training in order to promote muscle fullness and volumization. Do not take Humalin without carbohydrates.

Warnings & Precautions

Warning: Do not use by persons under the age of 18 years. Keep out of reach of children.

Do not use if pregnant or nursing. Consult your physician or pharmacist before using this product to assess possible interactions with medications.

Do not use if you have a heart, thyroid, or any known medical condition.

Formulation Notes

Glucose disposal agent + digestive support Muscle fullness Nutrient partitioning Insulin sensitivity Glucose balance

Digeseb Enzyme support complex proprietary product

Additional Information

Store in a cool dry place.

Scan here for more

In Condemned we trust @condemnedlabz Clearly there's a bigger problem here than I thought. A higher power with an even more corrupt agenda I'm not sure who or what we're fighting against anymore! Look at these shelves, these ingredients. They're poisoning us! This is genocide, we're under attack! Does anybody else see what's happening??? Am i the only one?

Metadata

Product Details

UPC / SKU8 69089 00028 4
DSLD Entry Date2025-05-21
Product TypeOther Combinations
FormCapsule
DSLD ID335660
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.